| Literature DB >> 16978919 |
Saul Yedgar1, Yuval Cohen, David Shoseyov.
Abstract
Phospholipase-A2 (PLA2) enzymes hydrolyze cell membrane phospholipids to produce arachidonic acid (AA) and lyso-phospholipids (LysoPL), playing a key role in the production of inflammatory lipid mediators, mainly eicosanoids. They are therefore considered pro-inflammatory enzymes and their inhibition has long been recognized as a desirable therapeutic target. However, attempts to develop suitable PLA2 inhibitors for the treatment of inflammatory diseases have yet to succeed. This is due to their functional and structural diversity, and their homeostatic and even anti-inflammatory roles in certain circumstances. In the present review we outline the diversity and functions of PLA2 isoforms, and their interplay in the induction and inhibition of inflammatory processes, with emphasis on discussing approaches for therapeutic manipulation of PLA2 activities.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16978919 DOI： 10.1016/j.bbalip.2006.08.003
Source DB: PubMed Journal: Biochim Biophys Acta ISSN： 0006-3002